Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

20:36 IST NSE
Earnings CallInfosys Ltd INFY

Infosys Earnings Call: Key Takeaways

Infosys crossed $20bn revenue in FY26, growing 3.1% in constant currency. Strategy focuses on AI leadership via 'Topaz Fabric' and 'Cobalt' platforms with significant expansion in Financial Services.

20:34 IST NSE
Capital Structure ChangeAimtron Electronics Ltd AIMTRON

Aimtron Electronics Capital Structure Change

Aimtron Electronics Limited allotted 2,32,180 equity shares worth ₹15.80 Crore upon the conversion of warrants. The allotment was made to 18 investors across promoter and non-promoter categories. Consequently, the company's paid-up capital increased to ₹20.84 Crore, with 9,61,856 warrants still outstanding for future conversion.

Value
₹15.80 Cr
20:32 IST NSE
Earnings Call360 One Wam Ltd 360ONE

360 One Wam Earnings Call: Key Takeaways

360 ONE WAM recorded its highest full-year PAT of ₹1,225 Cr (up 20.7%) in FY26. Strategy focuses on scaling HNI segments, integrating B&K Securities (360 ONE Capital), and leveraging AI for operational efficiency.

20:29 IST NSE
Management ChangeRossari Biotech Ltd ROSSARI

Rossari Biotech Management Change

Rossari Biotech Limited has appointed Mr. Udeypaul Singh Gill as a Non-Executive Independent Director for a 36-month term effective April 28, 2026. Mr. Gill brings over forty years of experience in chemicals, textiles, and sustainability. The appointment follows a board meeting outcome to strengthen the company's strategic leadership.

Execution
36 months
20:28 IST NSE
Board Meeting OutcomeAimtron Electronics Ltd AIMTRON

Aimtron Electronics Board Meeting Outcome

Aimtron Electronics approved its FY2026 audited standalone and consolidated financial results. Key outcomes include the allotment of 2,32,180 shares upon warrant conversion, implementation of a new ESOP scheme, and the appointment of secretarial auditors. The company also provided updates on business transitions and new contract closings for its subsidiaries.

20:28 IST NSE
Merger & RestructuringJagsonpal Pharmaceuticals Ltd JAGSNPHARM

Jagsonpal Pharmaceuticals Merger & Restructuring Worth ₹40 Cr

Jagsonpal Pharmaceuticals Limited has fixed May 04, 2026, as the record date for its buy-back of up to 16,00,000 equity shares. The buy-back is priced at ₹250 per share for a total aggregate amount of ₹40 Crore. This event determines shareholder eligibility for participation in the buy-back program.

Value
₹40.00 Cr
20:27 IST BSE
Board Meeting OutcomeCropster Agro Ltd ZPPOLYSA

Cropster Agro Board Meeting Outcome

Cropster Agro Ltd's board approved the appointment of Mr. Chirag Jonwal as an Independent Director and accepted the resignations of CFO Pavankumar Verma and Director Mahavirsinh Zala. The company is also relocating its registered office within Ahmedabad and reconstituting its Audit, Nomination, and Stakeholders committees effective April 27, 2026.